Physician profile
Ghislaine Robert
NPI 1679598510
$10,284.50
in general payments reported to CMS, 2019-2025
9 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.54 · 2021: $31.13 · 2022: $38.77 · 2023: $60.72 · 2024: $40.25 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $10K · Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $10,035.09 |
| Food and Beverage | $100.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $10,035.09 | 2025 | |
| Antares Pharma, INC. | $53.77 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Fidia Pharma USA INC. | $43.84 | 2019-2024 | Hymovis |
| Ferring Pharmaceuticals INC. | $33.81 | 2019 | |
| Depuy Synthes Sales INC. | $32.22 | 2023 | Peak, Orthovisc |
| Bioventus LLC | $31.13 | 2021 | |
| Orthofix Medical, INC. | $24.07 | 2024 | Physio-Stim |
| Sanofi-Aventis U.S. LLC | $17.07 | 2019 | |
| Avanos Medical | $13.50 | 2023 | Genvisc 850 Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghislaine Robert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.